Depression Decreases Adherence to COPD Maintenance Medications

Newswise — A recent study in the Annals of the American Thoracic Society found that in a nationally representative sample of Medicare beneficiaries who were newly diagnosed with COPD, adherence to maintenance medications decreased with new episodes of depression.

“With a prevalence of 17 to 44 percent, depression remains one of the most common, yet least recognized and under-treated, co-morbidities among patients with COPD,” said researcher Linda Simoni-Wastila, BSPharm, MSPH, PhD, a professor in the Department of Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy in Baltimore. “While depression has been associated with reduced maintenance medication use in other chronic conditions, this is the first study to document the role of causality of concomitant depression on reduced COPD medication adherence in older adults with COPD.”

In the study, “Adherence to Maintenance Medications Among Older Adults with Chronic Obstructive Pulmonary Disease: The Role of Depression,” researchers obtained Medicare administrative claims data from the Centers for Medicare & Medicaid Services Chronic Condition Data Warehouse and assessed a five percent random sample of Medicare beneficiaries (average age 68 years) from 2006‒2012. This included beneficiaries with two years of continuous Medicare Parts A, B and D coverage, and at least two prescription fills for inhaled corticosteroids, long-acting ß-agonists and long-acting anticholinergics.

Adherence was based on the number of prescriptions filled. Presence of depression was defined as at least one diagnosis code on at least one inpatient claim, or at least two outpatient claims during the study period.

Of the 31,033 beneficiaries meeting inclusion criteria, 20 percent were diagnosed with depression following COPD diagnosis. Average monthly adherence to COPD maintenance medications was low, peaking at 57 percent in the month following first fill, and decreasing to 25 percent within 6 months.

“We were able to identify depression as a risk factor for not using COPD medications, finding that older adults with respiratory disease have a tendency to not fully utilize the medications prescribed for their disease,” said Dr. Simoni-Wastila. The researchers also noted that “clinicians who treat older adults newly-diagnosed with COPD should be aware of the development of depression, especially during the first six months.”

“It is our long-term hope that this study will help policymakers, practitioners, and patients and their caregivers think of their health more holistically, and to consider how the presence of one treated or untreated medical condition may influence the progression and management of other medical conditions.”

The study was funded by the National Institutes of Health.

Contact for ArticleDr. Linda Simoni-Wastila, [email protected]

Share via Twitter#Depression is risk factor for #COPD medication noncompliance: new study.

Follow UsATS - @atscommunityAnnals - @AnnalsATSEditor

About the Annals of the American Thoracic Society (AnnalsATS)The AnnalsATS is a peer-reviewed journal published by the American Thoracic Society. The Journal delivers up-to-date and authoritative coverage of adult and pediatric pulmonary and respiratory sleep medicine and adult critical care. The scope of the Journal encompasses content that is applicable to clinical practice, the formative and continuing education of clinical specialists and the advancement of public health. Editor: John Hansen-Flaschen, MD, the Paul F. Harron Jr. Family Professor of Medicine at the University of Pennsylvania.

About the American Thoracic SocietyFounded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society’s 15,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes three journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology and the Annals of the American Thoracic Society.